急性深静脉血栓:AngioJet 后直接支架与分期支架对比
回顾性比较 91 例急性近端深静脉血栓合并髂股静脉狭窄患者,直接支架组 46 例、分期支架组 45 例,两组技术成功率均 100% 且无 30 天死亡;直接支架住院更短,但溶栓效果较低且 1 年 PTS 风险更高,1 年一期通畅率无差异。
要点
- 直接支架组 24 小时临床改善率 91%,高于分期组 73%(p<0.001)。
- 直接支架住院 4.59±0.91 天,短于分期组 5.8±1.6 天(p<0.001)。
- 直接支架溶栓效果较低且 1 年 Villalta 评分更差,提示 PTS 风险更高。
核心结论
- 两种支架策略对急性近端 DVT 均有效,直接支架住院更短但溶栓效果较低、1 年 PTS 风险更高。
研究设计与样本
- 单中心回顾性研究,2014 年 6 月至 2016 年 2 月共 91 例双功超声证实髂股静脉狭窄的 DVT 患者,直接支架组 46 例、分期支架组 45 例。
主要发现
- 两组技术成功率均 100%,无 30 天死亡;直接支架组 24 小时临床改善 42/46(91%),分期组 33/45(73%),p<0.001。
- 直接支架组住院 4.59±0.91 天,短于分期组 5.8±1.6 天(p<0.001)。
- 溶栓率直接组 81.50%±5.76%、分期组 85.67%±3.84%(p<0.001);VRI 两组均显著改善(p<0.001)。
- 分期组 Villalta 评分显著更优(p<0.001);直接组复发 DVT 2 例;1 年一期通畅率 93.5% 对 97.8%(p=0.323)。
关键数值与推荐
- 分期支架组采用 AngioJet 血栓清除加尿激酶导管接触溶栓后择期支架。
- 直接支架组在 AngioJet 血栓清除后即刻置入支架,所用支架更长但直径与分期组相近。
临床怎么用
- 急性近端 DVT 合并髂股静脉狭窄可考虑直接支架以缩短住院,但需权衡溶栓效果较低与 1 年 PTS 风险更高。
局限性
- 回顾性设计、单中心、样本量 91 例、随访 1 年,直接支架组支架更长可能影响比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the treatment outcomes in patients with acute proximal deep vein thrombosis (DVT) and iliofemoral stenosis who underwent either direct stenting after AngioJet rheolytic thrombectomy or staged stenting after AngioJet thrombectomy plus catheter-directed thrombolysis with urokinase. METHODS: From June 2014 to February 2016, 91 DVT patients underwent 2 treatments for duplex-verified iliofemoral stenosis: direct stenting (n = 46; mean age 54.8 years; 32 men) or staged stenting (n = 45; mean age 56.5 years; 27 men). The degree of patency after thrombectomy or thrombolysis was evaluated using the Venous Registry Index (VRI), while the risk of postthrombotic syndrome (PTS) was evaluated according to the Villalta scale. Patients were followed with periodic duplex ultrasound scans up to 1 year. RESULTS: The technical success rates were 100% in both groups; there was no 30-day mortality. Immediate (24-hour) clinical improvement was achieved in 42 (91%) of 46 direct group patients vs 33 (73%) of 45 staged group patients (p<0.001). A significant reduction (p<0.001) in the length of hospital stay was noted in the direct group (4.59±0.91) compared with that in the staged group (5.8±1.6). The stents used in the direct group were longer but with similar diameter compared with the staged group. The thrombolysis rates were 81.50%±5.76% in the direct group and 85.67%±3.84% in the staged group (p<0.001). The VRIs declined (improved) significantly in both groups (11.68±1.92 to 3.21±1.44 in the direct group and 12.17±2.29 to 2.36±1.19 in the staged group, both p<0.001). The Villalta scores were significantly better in the staged group (p<0.001). Recurrent DVT occurred in 2 patients in the direct group. The primary patency rates at 1 year were 93.5% in the direct group and 97.8% in the staged group (p=0.323). CONCLUSION: Both direct and staged stenting are effective treatment modalities for patients with acute proximal DVT. Compared with staged stenting, direct stenting provides similar treatment success and a significant reduction in the length of hospital stay; however, it has lower thrombolysis efficacy, and the risk of PTS at 1 year is greater with direct stenting.
引用
- Liu G, Qin J, Cui C, et al. Comparison of Direct Iliofemoral Stenting Following AngioJet Rheolytic Thrombectomy vs Staged Stenting After AngioJet Rheolytic Thrombectomy Plus Catheter-Directed Thrombolysis in Patients With Acute Deep Vein Thrombosis. J Endovasc Ther. 2017. PMID: 28618846. doi:10.1177/1526602817714570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。